ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
120.767,19
-1,73%
S&P 500
5.346,99
-0,11%
US Dollar vs BRL
5,3451
-0,02%
Bitcoin
69.384,25
0,07%
Brent Oil
79,395
0,00%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Immunomedics Inc (IMMU)

  7. Immunomedics Inc (IMMU) Notícias

IMMU

Immunomedics (IMMU)

Immunomedics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:IMMU
DataHoraFonteTítuloCódigoCompanhia
16/02/202117:31Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IMMUImmunomedics Inc
02/11/202010:27Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:IMMUImmunomedics Inc
30/10/202007:12Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:IMMUImmunomedics Inc
27/10/202020:22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMMUImmunomedics Inc
26/10/202007:02Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:IMMUImmunomedics Inc
23/10/202018:26Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:IMMUImmunomedics Inc
23/10/202018:24Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:IMMUImmunomedics Inc
23/10/202009:51Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:IMMUImmunomedics Inc
23/10/202008:58Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:IMMUImmunomedics Inc
23/10/202008:50Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:IMMUImmunomedics Inc
12/10/202009:00GlobeNewswire Inc.Immunomedics Announces FDA Orphan Drug Designation of Trodelvy™ for Adult and Pediatric GlioblastomaNASDAQ:IMMUImmunomedics Inc
24/09/202009:10Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:IMMUImmunomedics Inc
24/09/202009:01Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:IMMUImmunomedics Inc
21/09/202007:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMMUImmunomedics Inc
19/09/202012:00GlobeNewswire Inc.Immunomedics Announces Positive Results from Pivotal Phase 2 TROPHY U-01 Study of Trodelvy™ in Metastatic Urothelial Cancer...NASDAQ:IMMUImmunomedics Inc
19/09/202011:30GlobeNewswire Inc.Trodelvy™ Significantly Extends Survival in Phase 3 ASCENT Study of Metastatic Triple-Negative Breast CancerNASDAQ:IMMUImmunomedics Inc
18/09/202009:00GlobeNewswire Inc.Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain CancersNASDAQ:IMMUImmunomedics Inc
16/09/202017:59Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:IMMUImmunomedics Inc
14/09/202018:14Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:IMMUImmunomedics Inc
14/09/202009:26Dow Jones NewsImmunomedics Shares More Than Double After Gilead DealNASDAQ:IMMUImmunomedics Inc
14/09/202004:02Dow Jones NewsGilead Acquires Cancer-Drug Maker -- WSJNASDAQ:IMMUImmunomedics Inc
13/09/202022:01Dow Jones NewsGilead Reaches Deal to Buy Immunomedics for $21 Billion -- 5th UpdateNASDAQ:IMMUImmunomedics Inc
13/09/202017:29Dow Jones NewsGilead Reaches Deal to Buy Immunomedics for $21 Billion--4th UpdateNASDAQ:IMMUImmunomedics Inc
13/09/202016:00Business WireGilead Sciences to Acquire ImmunomedicsNASDAQ:IMMUImmunomedics Inc
12/09/202017:01Dow Jones NewsGilead Nears Deal to Buy Immunomedics for More Than $20 Billion--3rd UpdateNASDAQ:IMMUImmunomedics Inc
12/09/202016:50Dow Jones NewsGilead Nears Deal to Buy Immunomedics for More Than $20 Billion--2nd UpdateNASDAQ:IMMUImmunomedics Inc
12/09/202016:39Dow Jones NewsGilead Nears Deal to Buy Immunomedics for More Than $20 Billion--UpdateNASDAQ:IMMUImmunomedics Inc
12/09/202016:22Dow Jones NewsGilead Nears Deal to Buy Immunomedics for More Than $20 BillionNASDAQ:IMMUImmunomedics Inc
09/09/202008:00GlobeNewswire Inc.Immunomedics Announces Key Oral Presentations at ESMO Virtual Congress 2020NASDAQ:IMMUImmunomedics Inc
02/09/202009:00GlobeNewswire Inc.Immunomedics to Participate in Upcoming Healthcare ConferencesNASDAQ:IMMUImmunomedics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:IMMU

Seu Histórico Recente

BITMOT
835423
Gs Fin Corp Tf 4,15% Gn2...
NYSE
I-A
BOV
BCIC11
B-Index Morningstar Seto...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados